Join to View Full Profile
4921 Parkview PlDept OncologySaint Louis, MO 63110
Phone+1 314-747-7236
Fax+1 314-362-8099
Dr. DeSelm is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
Education & Training
Memorial Sloan Kettering Cancer CenterTranslational Research, 2017 - 2018- Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2013 - 2017
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2012 - 2013- Washington University in St. Louis School of MedicineClass of 2012
Certifications & Licensure
IL State Medical License 2020 - 2026
MO State Medical License 2018 - 2026
NY State Medical License 2013 - 2019
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Agilent 2020 Early Career Professor Award Agilent, 2020
- Early Independence Award (DP5) NIH
Publications & Presentations
PubMed
- 9 citationsChimeric antigen receptor macrophages target and resorb amyloid plaques.Alexander B Kim, Qingli Xiao, Ping Yan, Qiuyun Pan, Gaurav Pandey
JCI Insight. 2024-02-06 - 16 citationsProstate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach.Dhivya Sridaran, Elliot Bradshaw, Carl DeSelm, Russell Pachynski, Kiran Mahajan
Cell Reports. Medicine. 2023-10-17 - 6 citationsMemory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer.Miriam T Jacobs, Pamela Wong, Alice Y Zhou, Michelle Becker-Hapak, Nancy D Marin
Clinical Cancer Research. 2023-10-13
Abstracts/Posters
- MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T TherapyCarl DeSelm, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Th...Carl DeSelm, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Telluride Alum Receives Prestigious HonorOctober 23rd, 2020
Grant Support
- The Role Of Paxillin In The OsteoclastNational Institute On Aging2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
